Quetiapine safety in older adults: A systematic literature review

Keyphrases

• Adverse Drug Events 10%
• Adverse Events 10%
• Approved Indications 10%
• Cerebrovascular Accident 10%
• CINAHL 10%
• Cochrane Library 10%
• Cognitive Impairment 10%
• Dizziness 10%
• Exclusion Criteria 10%
• Full Characterization 10%
• Headache 10%
• Healthcare Providers 10%
• Increased Mortality 10%
• Injury Mortality 10%
• Low Risk 10%
• MEDLINE 10%
• Meta-analysis 10%
• Metabolic Disorders 20%
• Mortality Risk 10%
• Off-label Indications 10%
• Olanzapine 20%
• Older Adults 100%
• Older People 10%
• Parkinsonism 10%
• Patients with Dementia 10%
• Placebo 10%
• Postural Hypotension 10%
• Preferred Reporting Items for Systematic Reviews 10%
• PsycINFO 10%
• Quetiapine 100%
• Randomized Controlled Trial 20%
• Reduced Rate 10%
• Risperidone 20%
• Safety Profile 10%
• Second-generation Antipsychotics 20%
• Somnolence 10%
• Systematic Literature Review 100%
• Vulnerable Populations 10%
• Weight Gain 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Drug Reaction 10%
• Adverse Event 10%
• Antipsychotic 10%
• Cognitive Defect 10%
• Dizziness 10%
• Headache 10%
• Metabolic Disorder 20%
• Olanzapine 20%
• Orthostatic Hypotension 10%
• Parkinsonism 10%
• Placebo 10%
• Quetiapine 100%
• Randomized Controlled Trial 20%
• Risperidone 20%
• Somnolence 10%